Schrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) EV/Sales
As of 5 November 2026, Schrodinger, Inc. (SDGR) trades at a EV/Sales of 6.7×. Over the past ten years it has ranged from 0.9× (February 2020) to 59.2× (July 2020); the current reading is higher than 44% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.6× | (28.58%) |
| FY2024 | 5.0× | (47.40%) |
| FY2023 | 9.5× | 102.44% |
| FY2022 | 4.7× | (65.65%) |
| FY2021 | 13.6× | (64.16%) |
| FY2020 | 38.0× | 3,696.89% |
| FY2019 | 1.0× | 0.00% |
| FY2018 | 1.0× | 0.00% |
| FY2017 | 1.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 7.2× | 136.08% |
| Jun 2026 | 3.1× | 80.28% |
| Mar 2026 | 1.7× | (52.16%) |
| Dec 2025 | 3.6× | (14.97%) |
| 27 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| PRVA Privia Health Group, Inc. compare | 1.1× |
| TDOC Teladoc Health, Inc. compare | 1.2× |
| OMCL Omnicell, Inc. compare | 1.4× |
| GDRX GoodRx Holdings, Inc. compare | 1.8× |
| HSTM HealthStream, Inc. compare | 2.4× |
| OMDA Omada Health, Inc. compare | 3.0× |
| CERT Certara, Inc. compare | 4.9× |
| SDGR Schrodinger, Inc. | 6.7× |
| HTFL Heartflow, Inc. compare | 21.4× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement